Le Lézard
Classified in: Health, Science and technology
Subjects: PER, TRI

ClinOne Names Cameron Snider VP of Business Development to Help Sponsors, CROs, and Sites Transform the Patient Experience in Global Clinical Trials


DENVER, April 19, 2021 /PRNewswire-PRWeb/ -- ClinOne, a leader in virtual trial management, took another major step in expanding the reach of its clinical research platform by welcoming industry executive Cameron Snider (LinkedIn) as Vice President of Business Development.

Cameron brings ClinOne a unique perspective that combines business development and operations to support the world's largest pharmaceutical companies. Throughout his career, he has developed a reputation for building deep and trusted relationships with sponsors and CROs researching many therapeutic areas across the clinical trial industry.

Cameron has held key leadership positions in seminal clinical technology companies he helped make highly successful, including TrialNetworks and DrugDev, where he led enterprise-wide sales to strategic Top 20 pharmas. After IQVIA acquired DrugDev, Cameron expanded his portfolio to include an operational role as Head of Global Delivery with a particular focus on a global COVID vaccine program.

"We're thrilled that of all the companies Cameron could have joined, he chose ClinOne," said ClinOne CEO and Co-founder Rob Bohacs (LinkedIn). "I am truly inspired by our team ? and every time we add another experienced industry leader like Cameron it further validates the value of our platform and the passion we share for transforming the patient experience. The management team at ClinOne is the best of the best, and our company is being built by proven experts who spent decades leading many of the largest providers in our industry. Demand for our solutions continues to grow at triple-digit annual rates, and Cameron will help us harness and grow that demand with new and repeat customers."

At ClinOne, Cameron will be responsible for driving growth of the company's platform which includes solutions for enterprise-wide eConsent, specialist referrals, patient engagement, dosing management, connected devices, and eSource.

"I've been fortunate to have played a role in some amazing achievements throughout my career, from startup successes to the groundbreaking pace of a global COVID vaccine program," said Snider. "Now, I'm ready to bring those learnings to a new challenge, and I am honored to join this remarkable team. It is rare to find a company like ClinOne with every ingredient in place for success ? from its executives and brilliant technology to its global operations and visionary roadmap for growth. I'm excited to be here and I can't wait to share why I'm so impressed by the ClinOne platform."

"With Cameron leading our business development team, we're ready to help the world make clinical trials a little easier, every day," added Bohacs.

To learn more or request a demo, visit http://www.clinone.com.

About ClinOne

The new era of clinical research has arrived. We help you lead the way with a single virtual platform to simplify patient enrollment, consent, data capture, compliance, and engagement. Featuring proven global logistics, the industry's fastest implementation timelines, and an all-star team of senior executives, technologists and service professionals, ClinOne makes clinical research a little easier, every day, for patients and sites worldwide. How can we help you? Bring your challenges and find your solutions at http://www.clinone.com.

Media Contact

Brenda Nashawaty, ClinOne, +1 617-688-253, [email protected]

 

SOURCE ClinOne


These press releases may also interest you

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Stevanato Group S.p.A. , a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first...

at 16:05
Bruker Corporation today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current...

at 16:05
Gilead Sciences, Inc. announced today its first quarter 2024 results of operations. "Gilead delivered another strong quarter of revenue growth in the first quarter with 6% year-over-year growth in our base business driven by HIV, Oncology and...

at 16:05
DexCom, Inc. today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an...

at 16:05
Ironwood Pharmaceuticals, Inc. today announced it will host its first quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 9, 2024. Individuals interested in participating in the call should dial (888)...



News published on and distributed by: